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In epidermis, metabolism of histidine ter-
minates with the formation of urocanic acid
(RCA) (1). UCA accounts for about 80% of
the LW absorbancy of acid soluble extracts of
guinea pig epidermis (2). It has also been shown
that only the trans isomer of UCA is present in
normal epidermis, but following exposure of
skin to IJV a mixture of the cis and trans
isomers is formed (3, 4). In a study employ-
ing RCA, Kuroguchi et al. investigated the
effect of rabbit liver homogenates on cis RCA
and found no decrease in 3 hours, while a little
degradation was found after 24 hours (5). This
report is concerned with disposition of cis UCA
by mammals.
MATERIALS
Trans UCA. Trans UCA was purchasedt or
synthesized in this laboratory by the method of
Pyman (6) or Anatol (7). Labeled ( C'4) trans
RCA was preparedi: by a modification of the latter
method, that is by condensation of imidozole 4-al-
dehyde and 2-C'4 malonic acid. It had a specific
activity of 1.4 ic/eM.
Cis UCA. A mixture of cis and trans isomers of
RCA was prepared by irradiation of aqueous solu-
tions of 7.0 emoles trans UCA, PH 8.0, with 6.7 X
10' Einsteins of 280—320 mj light. The cis isomer
was isolated from the irradiation mixture by ion-
exchange procedures described below.
Animals. White male guinea pigs weighing 300—
700 gm or rats weighing 250—350 gm. were used in
the experiments involving laboratory animals.
METHODS
Ion-exchange chromatography. Anion-exchange
chromatography employing Dowex-1-acetate in a
gradient elution scheme as described previously
(8) effectively separates the cis and trans isomers
of UCA. If urine or other solutions containing
relatively large amounts of other anions are chro-
matographed, elution of the UCA isomers from
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Dowex-1 is delayed, but ci.s RCA is invariably
eluted before the trans isomer. In addition, urine
contains many UV absorbing substances which in-
terfere with spectrophotometric detection. For
these reasons labeled cis RCA was added to the
urine before ion exchange chromatography to facil-
itate recognition of fractions containing this sub-
stance. Radioactive fractions from the anion
exchanger contained appreciably more TJV ab-
sorbancy than that associated with the labelled
cis RCA added to the urine aliquot. These fractions
were pooled and adjusted to pH 3.0 for absorption
on Dowex-50-H (cation exchanger). When eluted
with 7.0% NaCl in a gradient scheme the fractions
containing radioactivity were collected.
Lyophilization of fractions collected from the
cation exchanger yielded a product with a low con-
centration of cis UCA in NaCI. The ialt was re-
moved from the cis UCA by dilution to 3% NaCl
and reabsorption on the same cation exchanger.
This was followed by washing with water and elu-
tion with 0.5N NaOH. Fractions 20—30 contained
radioactivity and were neutralized with acetic acid.
When reabsorbed on Dowex-1-acetate and eluted
with 0.04N acetic acid as described above, cis RCA
was obtained free from NaCl.
Thin layer chromatography. Materials to be in-
vestigated by thin layer chromatography were
applied to commercial silica gel chromatographic
sheets It and developed in small chromatographic
chambers by the ascending technique. The solvents
employed were: n-butanol/acetic acid/H,O (60/
25/15), n-propanol/ammonia (sp gr. 0.90/H2O
(60/30/10), n-butanol/ethylacetate/acetic acid!
11,0 (1/1/1/1), n-butanol/acetic acid/11,O (2/1/1),
all prepared in volume ratios. Chromatograms
were developed either unidirectionally, adjacent
to authentic materials, or in 2 dimensions using
different solvents. Alkaline diazo reagent (8) was
employed for chemical detection of imidazoles and
autoradiography was utilized for localizing radio-
activity.
The RCA recovered from urine by application
of the ion-exchange procedures, was further pun-
fled for JR Spectrum determination by thin layer
chromatography. The material was applied to
Merck TLC plates and developed in the propanol/
ammonia system described above. When the
chromatograms were examined under 2537 mg
light the UV absorbancy seen was at the R, ex-
pected for cis RCA. Silica gel from the RV ab-
sorbing area on the plate was removed and col-
lected. Elution of cis RCA from the collected
II Eastman Chromagram sheet, type K 301R2,
Eastman Kodak, Rochester, N.Y. TLç-plates
Silica Gel F254, E. Merck. Darmstadt, Bninkman
Instruments, Westbury, N.Y.
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Fia. 1. Autoradiogram print of C'4 labeled cis
IJCA. (A) starting cis IJCA in 1% NaC1 (B)
radioactivity in urine eluted from anion exchanger
after oral administration of 014 labeled cis UCA
to a rat. (C) radioactivity from a 15% guinea pig
epidermal homogenate incubated with C' cis UCA
for 4 bours at 22° in 1% NaCl. (D) Same as (C)
except incubated in 0.15 M phosphate buffer pH
6.8. Solvent: Propanol/ammonia/H20 (60/30/10).
silica gel with water and lyophilization of the elu-
ent yielded the cis UCA recovered from urine that
was incorporated into a KBr pellet for Infra-red
(IR) Spectrum determination.
Autoradiography. Thin layer chromatograms
with spots of the starting cis UCA and radioactiv-
ity recovered from urine or from incubation of ci.s
UCA with organ homogenates were developed in
the manner described. After air drying, the chro-
matograms were placed in contact with photo-
graphic film and indexed. Following exposure to
approximately 1 >< 106 atomic disintegrations (2—10
days) the film was removed and developed in the
usual manner. The location of darkening of the
photographic emulsion by radioactivity was com-
pared with that of the color produced by chemical
spray reagents for imidazoles.
Analytical Procedures. A Gary Model 14 Spec-
trophotometer was used for determination of the
molar extinction coefficient (18,000 at 265 m/z)
employed for spectrophotometric quantitation of
UCA. A model JR-b Beckman JR spectrophotom-
eter was employed for determination of IR
spectra in KBr pellets.
A model 880 Vanguard chromatogram scanner
was used for all radioisotope determinations. Meas-
ured aliquots of organ extracts or urine were ap-
plied to filter paper, dried and positioned within
the counting chamber. The count rate was read
from the rate meter. The counting efficiency was
30% with a precision of
Homogenates. A motor driven, all glass tissue
grinderJ was used to prepare the homogenates
from shaved rat or guinea pig epidermis collected
by the scraping technique (0). The tube was
cooled during the grinding operation to reduce
heating by friction. Approximately 30% suspen-
sions were prepared in physiological saline. A simi-
lar procedure was employed in preparation of
liver and kidney homogenates.
RESULTS
Incubation of 011 Cis UCA with Organ
Homogenates. Investigation of the chromato-
graphic behavior of the radioactivity recovered
from homogenates of skin, liver and kidney
when incubated with labeled cis UCA at 22°
for 24 hours gave no indication that any new
radioactive substance had been formed either
by the homogenate or by contaminating bac-
teria. It was established that the chromato-
graphic solvent systems which were employed
would resolve cis and trans UCA, imidazole
obtained in several similar experiments.
Investigation of the chromatographic prop-
erties of the radioactivity in the urine by
anion-exchange showed it to be similar to the
cis UCA which was injected. When further
characterized by thin layer chromatography
using a variety of solvent systems, the re-
covered urinary radioactivity had the same
mobilities as cis UCA.
Following intraperitoneal injection of trans
UCA 98,000 cpm (0.35 molc) the urine col-
lected during the next 24 hours contained no de-
¶Kontes Glass Company, Vineland, New Jersey.
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propionic acid and glutamic acid, substances
likely to be formed by enzymatic modification
of cis UCA. Figure 1 is an autoradiogram of
radioactivity recovered from urine or homoge-
nates and compared with that of cis UCA.
Intraperitoneal injection. Cis UCA, having
270,000 cpm (0.46 emoles) was dissolved in
physiological saline (pH 7.0) and injected intra-
pcritoneally into a white male rat weighing 280
gm. The urine collected in the next 4 hours
contained 70% of the radioactivity injected. In
the interval of the next 20 hours 19% was
recovered in the urine making a total of 89%
recovered within 24 hours. Table I lists the data
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tectable radioactivity. Apparently the labeled
trans TJCA was degraded by urocanase and was
not excreted by the kidney.
Feeding experiments. Administration of
300,000 cpm (0.63 emoles) C14-tagged cis TJCA
by stomach tube to a 300 gm. white male rat
yielded 75% of the count in the urine within
four hours and an additional 25% in the urine
within the next 20 hours. This accounts for all
of the ingested count. Investigation of the uri-
nary radioactivity by means of ion-exchange
and thin layer chromatography indicated that
this product was cis TJCA. Table II lists the data
obtained in this and two other similar experi-
ments.
Irradiation in vivo. The cis UCA content in
the urine collected during 24 hours following
whole body irradiation of a normal 22 year old
white male exposed to 3 minimal erythema
doses of UV was evaluated. The maximum uri-
nary cis UCA content was determined employ-
ing a modification of the isotope dilution pro-
cedure wherein the 265 m absorbancy and
count rate of labeled cis 1IJCA added to a ali-
quot of the urine was compared with that iso-
lated. The data indicated that less than 1 X
10 moles cis UCA was contained in the 24
hour specimen.
Oral administration. Following oral adminis-
tration of 3 mg. non-labeled cis UCA to a 45
TABLE I
Urinary excretion of G' labeled cis UCA
injected intraperitoneally
Animal Wt.
CPM X 10-'
Admin-
istered Found in urine
Animal w•
CPM X 101
Ad
minis-
tered
Found in urine
Rat
Rat
Rat
300 gm
300 gm
330 gm
300
250
100
0—4 hr.
226
(75%)
92
(37%)
17
(17%)
0—8 hr.
255
(85%)
—
—
0—24 hr.
301
(100%)
155
(62%)
77
(77%)
0—48 hr.
301
(100%)
200
(80%)
89
(89%)
year old white male the urine was collected for
48 hours. The cis isomer administered was 90%
accounted for in the urine by application of the
ion-exchange techniques described above.
Infrared spectra. Comparison of the JR
spectrum of cis UCA recovered from urine
after purification on both anion and cation
exchangers showed absorption maxima at fre-
quencies not observed in the spectrum of au-
thentic cis UCA. When it was further puri-
fied by thin layer chromatography comparison
of the JR spectra of this material with that of
authentic cis UCA showed that absorption
maxima were present at the same frequencies.
DISCUSSION
The initial experiments employing labeled
cis IJCA utilized homogenates prepared from
epidermis, liver and kidney. The enzymatic
changes of cis UCA by organ homogenates
considered most likely were, isomerization to
trans UCA, reduction to imidazole propionic
acid, or conjugation with an amino acid or
sugar derivative. There was no indication that
any new C15 labeled product had been formed.
The possibility that cis UCA is modified in
vivo was investigated by intraperitoneal injec-
tion of labeled cis UCA. Determination of the
radioactivity in urine showed that, within ex-
perimental error, all of the label was excreted
within 24 to 48 hours. Separation of the radio-.
activity from urine by both anion and cation
exchange and determination of the mobility of
the radioactivity in thin layer chromatographic
systems indicated that all of the label was asso-
TABLE II
Urinary excretion of C14 labeled cis UCA
administered orall
0-4 hr. 0—s hr. 0—24 hr. 0-48 hr.
190 228 241 241
70% 84
Rat
Rat
Rat
Rat
Guinea
Pig
280 gm
350 gm
300 gm
300 gm
500 gm
270
1740
210
32
600
21.4
66%
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ciated with unchanged cis UCA. The same re-
suits were obtained when cis UCA was admin-
istered by mouth, confirming that the liver does
not modify this pbotoproduct.
To investigate the urinary excretion of cis
UCA formed in situ, a normal adult male was
irradiated with DV and the urine was collected
for 24 hours. Addition of labeled ins UCA to
an aliquot of the urine followed by separation
of the cis UCA and subtraction of DV absorb-
ancy attributable to the exogenous UCA left es-
sentially no DV absorbancy to be attributed to
cis UCA transported from the epidermis to the
urine. In addition, it was found that about the
same increment of DV absorbancy was seen
by application of identical separation pro-
cedures to urine of the subject from the 24
hours preceding DV irradiation.
5UMMARY
1. Experiments in vitro with skin, liver or
kidney homogenates indicated that cis UCA
was not metabolized.
2. When administered orally or intraperi-
toncally cis IJCA was neither degraded nor con-
jugated but was excreted by the kidney un-
changed.
3. Cis UCA formed in viva by DV irradia-
tion of epidermis was not found in the urine
within 24 hours after irradiation. Thus, cis
UCA formed in situ by DV irradiation does
not normally enter the systemic circulation.
REFERENCES
1. Schwarz, E.: Abban von histidin zu urocanin-
sSure in der epidermis. Biochem. z, 334: 415,
1961.
2. Tabachnick, J.: The free amino acids, ammonia,
urocanic acid and nucleic acid content of nor-
mal albino guinea pig epidermis. J. Invest.
Derm.,32: 563, 1959.
3. Anglin, J. H., Jr., Bever, A. T., Everett, M. A.
and Lamb, J. H.: Ultraviolet light induced
alterations in urocanic acid in vivo. Biochem.
Biophys. Acta, 53: 40S, 1961.4. Pascher, 9.: Cis- and trans-urocaninsäure als
bestandtile des stratum corneum. Arch. Klin.
Exp. Dermat., 214: 234, 1962.
5. Kuroguchi, Y., Fukui, Y., Nakagawa, T. and
Yamamoto, I.: A note on cis urocanic acid.
Jap. J. Pharmacol., 6: 147, 1957.
6. Pyman, F. L.: A new synthesis of histamine(4 (5)-p Amino ethylglyoxahne). J. Chem.
Soc., 1911 Part 1: 668.
7. Anatol, Jesus: French Patent Number 1,254,992,
Chem. Abs., 57: 5930, 1962.
S. Anghn, J. 11., Jr. and Eyerett, M. A.: Photo-
dimerization of urocanic acid in viva and in
vitro. Biochem. Biophys. Acta, 88: 492, 1964.
9. Ogura, H., Knox, J. M. and Griffin, A. C.: Sepa-
ration of epidermis for the study of epidermal
sulfhydryl. J. Invest. Derm., 35: 239, 1960.
